Who Paid My Doc
cobas LIAT Analyzer
Device Molecular Diagnostics
PDI 07613336100097
General payments
$4,032
Research payments
$6,516,100
Through program year 2025, $4,032 in general payments and $6,516,100 in research payments were reported against cobas LIAT Analyzer (Molecular Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,123 | 48 |
| 2025 | Research | $3,915,810 | 258 |
| 2024 | General | $245 | 10 |
| 2023 | General | $1,342 | 30 |
| 2023 | Research | $338,201 | 96 |
| 2022 | General | $272 | 4 |
| 2022 | Research | $2,163,799 | 160 |
| 2021 | General | $1,050 | 3 |
| 2021 | Research | $98,290 | 4 |
Breakdown
The top 5 of 48 recipients; each share is of general payments naming this product in 2025.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
95 general · 518 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.